Swedish Orphan Biovitrum AB Sweden

Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

View original content:https://www.prnewswire.co.uk/news-releases/sobi-receives-positive-chmp-opinion-recommending-approval-of-efanesoctocog-alfa-for-once-weekly-treatment-of-haemophilia-a-302128647.html